Journal History

2003 Marine Drugs is founded at the Ocean University of China. Prof. Dr. Hua-Shi Guan is the founding Editor-in-Chief. Inaugural volume is released, initially published as a quarterly journal.
2005 Marine Drugs is indexed by Science Citation Index Expanded (SCIE).
2007 Marine Drugs is covered by PubMed.
2010 Marine Drugs becomes a monthly journal and is covered by Scopus. The 2010 impact factor for Marine Drugs increased to 3.471, meaning Marine Drugs has become the leading open access journal in the field of drugs sourced from the maritime environment.
2011 Four active Associate Editors are added. They have previously served on the Editorial Board: Prof. Dr. Nobuhiro Fusetani, Prof. Dr. Alejandro M. Mayer, Prof. Dr. Jordan K. Zjawiony and Prof. Dr. Guido Cimino.
2012 The 2011 impact factor for Marine Drugs increases to 3.854.
2013 The impact factor continues to increase to 3.978. Marine Drugs is ranked 6/59 in the Medicinal Chemistry category of SCIE. Marine Drugs launches its Best Paper Award. Marine Drugs sponsors the 14th International Symposium on Marine Natural Products (MANAPRO 2013).
2014 The impact factor is 3.512, and Marine Drugs is ranked 10/58 in the Medicinal Chemistry category of SCIE. Marine Drugs sponsors the 2014 Gordon Research Conference on Marine Natural Products and the 2014 Oceans & Human Health Gordon Research Conference. Associate Editors increased to 5 members: Prof. Dr. Nobuhiro Fusetani, Prof. Dr. Jordan K. Zjawiony, Prof. Dr. Orazio Taglialatela-Scafati, Dr. Peer B. Jacobson and Dr. Keith B. Glaser.
2015 The impact factor is 2.853, and Marine Drugs is ranked 22/59 in the Medicinal Chemistry category of SCIE. Marine Drugs sponsors and collaborates with more conferences, including the 9th European Conference on Marine Natural Products, the 1st Congress of Marine Fungal Natural Products Consortium, 2015 Gordon Research Conference in Heterocyclic Compounds, and the 1st Sino-Italian symposium on Natural Products. It also builts a relationship with TASCMAR (an EU project). The Twitter account for Marine Drugs is created.
2016 The impact factor increases to 3.345, and Marine Drugs is ranked 13/59 in the Medicinal Chemistry category of SCIE. Marketing promotion continues to be enlarged. The Young Investigator Award is offered.
2017 The impact factor increases to 3.503, ranked 13/60 in Category "Chemistry, Medicinal" in SCIE.
2018 The impact factor increases to 4.379, ranked 5/59 in Category "Chemistry, Medicinal" in SCIE.
2019 The impact factor is 3.772, ranked 15/61 (Q1) in Category “Chemistry, Medicinal” in SCIE. Prof. Dr. Bill J. Baker was appointed as Associate editor of Marine Drugs.
2020 The Impact Factor increases to 4.073 in Journal Citation Reports/Science Edition (Clarivate Analytics) Category "Chemistry, Medicinal". The CiteScore is 5.1 in Scopus Category 'Drug Discovery'. Prof. Dr. Marc Diederich has been appointed as Associate Editor of Marine Drugs in December. Australia New Zealand Marine Biotechnology Society (ANZMBS) is affiliated with Marine Drugs and its members receive a discount on article processing charges.
2021 The Impact Factor increases to 5.118 in Journal Citation Reports/Science Edition (Clarivate Analytics), and the quartile is Q1 in both the old category "Chemistry, Medicinal" (12/62) and the newly added category "Pharmacology & Pharmacy" (60/276). The CiteScore increases to 6.4 in Scopus, and percentile is 86% in Category "Pharmacology, Toxicology and Pharmaceutics (miscellaneous)" (newly added), 83% in "Pharmaceutical Science", and 78% in "Drug Discovery".
2022 The year 2022 marks the 20th Anniversary of Marine Drugs.

Editors-in-Chief

2003–2005 Editor-in-Chief: Prof. Dr. Hua-Shi Guan
2005–2009 Editor-in-Chief: Prof. Dr. Peter Proksch
2009–2013 Editor-in-Chief: Prof. Dr. Hartmut Laatsch
2014–2018 Editor-in-Chief: Prof. Dr. Alejandro M. Mayer
2018–Present Editor-in-Chief: Prof. Dr. Orazio Taglialatela-Scafati

Section Editor-in-Chief

2022–present

Section Editor-in-Cheif: Prof. Dr. Anake Kijjoa for the Section on Structural Studies on Marine Natural Products
Section Editor-in-Cheif:
Prof. Dr. Vassilios Roussis for the Section on Marine Chemoecology for Drug Discovery
Section Editor-in-Cheif:
Prof. Dr. Marialuisa Menna for the Section on Synthesis and Medicinal Chemistry of Marine Natural Products
Section Editor-in-Cheif:
Prof. Dr. Bill J. Baker for the Section on Marine Toxins
Section Editor-in-Cheif:
Prof. Dr. Marc Diederich for the Section on Marine Pharmacology

Back to TopTop